文献速递运动医学关节外科

小鼠肩胛上神经压迫解除后脂肪浸润的逆转依赖于UCP1表达

Reversal of Fatty Infiltration After Suprascapular Nerve Compression Release Is Dependent on UCP1 Expression in Mice.
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

研究建立可逆性小鼠肩胛上神经压迫模型,发现压迫可诱导神经损伤和肩胛上肌脂肪浸润,解除压迫后损伤和脂肪浸润均逆转,且该逆转依赖UCP1介导的白色脂肪棕色化。作者认为若人类中确认此机制,UCP1激动剂可能成为肩胛上神经损伤的有效治疗。

要点

  • 小鼠肩胛上神经压迫诱导神经损伤和脂肪浸润,解除压迫后均可逆转。
  • UCP1敲除小鼠压迫解除后脂肪面积分数无变化,提示逆转依赖UCP1。
  • 作者认为若人类确认棕色化机制,UCP1激动剂可能有效治疗肩胛上神经损伤。

核心结论

  • 作者建立了一种临床相关的可逆性小鼠肩胛上神经压迫模型,压迫解除后脂肪浸润吸收由白色脂肪棕色化介导。

研究设计与样本

  • C57BL/6J小鼠随机分为神经切断组(n=10)、神经压迫组(n=10)、神经压迫并解除组(n=10)和假手术对照组(n=10)。
  • 另用UCP1报告小鼠(神经压迫n=4,压迫并解除n=4)和UCP1敲除小鼠(神经压迫n=4,压迫并解除n=4)研究白色脂肪棕色化的作用。
  • 采用锇酸染色和神经肌肉接头染色半定量神经损伤,油红O染色半定量脂肪浸润,免疫荧光和油红O染色检测UCP1转基因小鼠。
  • 由盲法评价者测量UCP1阳性染色面积和脂肪面积与肌肉横截面积比值。
  • 组间比较采用方差分析及Tukey事后检验。

主要发现

  • 退变轴突比例:假手术对照组6%±3%(95%CI 3%-10%);神经压迫组58%±10%(95%CI 45%-70%,与假手术组比较p<0.001);神经压迫并解除组15%±9%(95%CI 5%-26%,与假手术组比较p=0.050)。
  • 肩胛上肌脂肪浸润面积百分比在神经压迫6周后升高至19%±1%(95%CI 18%-20%,p<0.001),而压迫解除6周后为5%±3%(95%CI 1%-10%,与假手术组比较p=0.054),假手术组为2%±1%(95%CI 1%-3%)。
  • UCP1敲除小鼠神经压迫解除后脂肪面积分数无变化:压迫2周后为6%±1%(95%CI 4%-8%),解除2周后为5%±0.32%(95%CI 4%-6%),p=0.1095。

临床怎么用

  • 作者认为,若白色脂肪棕色化机制在人类肩袖肌脂肪浸润中得到确认,UCP1激动剂可能成为肩胛上神经损伤患者的有效治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In large rotator cuff tears, retraction of the supraspinatus muscle creates suprascapular nerve traction and compression. However, suprascapular nerve transection, when used in previous models, is different from chronic compression of the suprascapular nerve in patients. To define the role of suprascapular nerve chronic injury in rotator cuff muscle atrophy and fatty infiltration, we developed a novel reversible suprascapular nerve compression mouse model. QUESTIONS/PURPOSES: We asked: (1) Can suprascapular nerve injury be induced by compression but reversed after compression release? (2) Can muscle fatty infiltration be induced by suprascapular nerve compression and reversed after compression release? (3) Is white fat browning involved in fatty infiltration resorption? METHODS: Mice in a common strain of C57BL/6J were randomly assigned to suprascapular nerve transection (n = 10), nerve compression (n = 10), nerve compression and release (n = 10), or sham control (n = 10) groups. To study the role or white fat browning on muscle fatty infiltration, additional UCP1 reporter mice (n = 4 for nerve compression and n = 4 for nerve compression release) and knockout mice (n = 4 for nerve compression and n = 4 for nerve compression release) were used. Nerve injury was testified using osmium tetroxide staining and neural muscular junction staining and then semiquantified by counting the degenerating axons and disrupted junctions. Muscle fatty infiltration was evaluated using Oil Red O staining and then semiquantified by measuring the area fraction of fat. Immunofluorescent and Oil Red O staining on UCP1 transgenic mice was conducted to testify whether white fat browning was involved in fatty infiltration resorption. Ratios of UCP1 positively stained area and fat area to muscle cross-section area were measured to semiquantify UCP1 expression and fatty infiltration in muscle by blinded reviewers. Analysis of variance with Tukey post hoc comparisons was used for statistical analysis between groups. RESULTS: Suprascapular nerve injury was induced by compression but reversed after release. The ratios of degenerating axons were: sham control: 6% ± 3% (95% confidence interval [CI], 3%-10%); nerve compression: 58% ± 10% (95% CI, 45%-70% versus sham, p < 0.001); and nerve compression and release: 15% ± 9% (95% CI, 5%-26% versus sham, p = 0.050). The supraspinatus muscle percentage area of fatty infiltration increased after 6 weeks of nerve compression (19% ± 1%; 95% CI, 18%-20%; p < 0.001) but showed no difference after compression release for 6 weeks (5% ± 3%; 95% CI, 1%-10%; p = 0.054) compared with sham (2% ± 1%; 95% CI, 1%-3%). However, the fat area fraction in UCP1 knockout mice did not change after nerve compression release (6% ± 1%; 95% CI, 4%-8% at 2 weeks after compression and 5% ± 0.32%; 95% CI, 4%-6% after 2 weeks of release; p = 0.1095). CONCLUSIONS: We developed a clinically relevant, reversible suprascapular nerve compression mouse model. Fatty infiltration resorption after compression release was mediated through white fat browning. CLINICAL RELEVANCE: If the mechanism of browning of white fat in rotator cuff muscle fatty infiltration can be confirmed in humans, a UCP1 agonist may be an effective treatment for patients with suprascapular nerve injury.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Wang Z, Feeley BT, Kim HT, et al. Reversal of Fatty Infiltration After Suprascapular Nerve Compression Release Is Dependent on UCP1 Expression in Mice. Clin Orthop Relat Res. 2018. PMID: 30020151. doi:10.1097/CORR.0000000000000335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。